复发经典型霍奇金淋巴瘤儿童患者中抗PD-1治疗相关1型糖尿病一例
本文报告一例12岁西班牙裔男孩,患有霍奇金淋巴瘤,在接受自体造血干细胞移植后疾病进展,使用帕博利珠单抗治疗五周期后因糖尿病酮症酸中毒入院,诊断为免疫检查点抑制剂相关1型糖尿病,出院后需每日胰岛素注射。作者指出儿童中需监测和教育ICI相关糖尿病。
要点
- 儿童患者接受帕博利珠单抗五周期后发生糖尿病酮症酸中毒,诊断为ICI相关1型糖尿病。
- 患者出院后需每日胰岛素注射并持续外源性胰岛素治疗。
- 作者认为需对儿童进行ICI相关糖尿病的监测和教育。
核心结论
- ICI使用扩大可能导致儿童患者中出现更多ICI相关糖尿病病例,如同在成人中观察到的。
- 考虑到糖尿病的急性表现和终身胰岛素治疗的额外负担,尤其对儿童患者及其家庭,需要对儿童ICI相关糖尿病进行监测和教育。
研究设计与样本
- 本文描述一例12岁西班牙裔男孩的儿科病例,该患者患有霍奇金淋巴瘤,有自体造血干细胞移植史,疾病进展后接受帕博利珠单抗治疗。
主要发现
- 患者在帕博利珠单抗五周期后因糖尿病酮症酸中毒入院。
- 患者出院时需每日胰岛素注射,并自此持续使用外源性胰岛素。
临床怎么用
- 作者认为需要对儿童进行ICI相关糖尿病的监测和教育。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Immune checkpoint inhibitors (ICIs) perturb T-cell regulatory pathways to enhance antitumor immunity. However, an increase reporting of ICI-associated diabetes is observed in adults. To our knowledge, no cases have been reported in the pediatric population. RESEARCH DESIGN AND METHODS: We describe a pediatric case of ICI-associated type 1 diabetes in a 12-year-old Hispanic boy with Hodgkin lymphoma. The patient had a history of autologous hematopoietic stem cell transplantation and was treated with pembrolizumab after disease progression. RESULTS: The patient was admitted for diabetic ketoacidosis after five cycles of pembrolizumab. The patient was discharged with daily insulin injections and has continued on exogenous insulin ever since. CONCLUSIONS: The expanded ICI use may lead to more cases in pediatric patients as has been observed in adults. Considering the acute manifestation of diabetes and the added burden of lifelong insulin therapy, in particular for pediatric patients and their families, monitoring and education of ICI-associated diabetes in children is needed.
引用
- Samoa RA, Lee HS, Kil SH, et al. Anti-PD-1 Therapy-Associated Type 1 Diabetes in a Pediatric Patient With Relapsed Classical Hodgkin Lymphoma. Diabetes Care. 2020. PMID: 32616607. doi:10.2337/dc20-0740
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。